Molecular studies of leptin: implications for renal disease.
Stenvinkel
P
P
Department of Clinical Science, Huddinge University Hospital, Sweden.
Lönnqvist
F
F
Schalling
M
M
D000818:Animals; D001066:Appetite / Q000187:drug effects; D001693:Biological Transport, Active; D001812:Blood-Brain Barrier; D002352:Carrier Proteins / Q000502:physiology; D002490:Central Nervous System / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D005938:Glucocorticoids / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000502:physiology; D007674:Kidney Diseases / Q000235:genetics / Q000503:physiopathology*; D020738:Leptin; D008297:Male; D051379:Mice; D009765:Obesity / Q000235:genetics / Q000503:physiopathology; D011506:Proteins / Q000235:genetics* / Q000494:pharmacology / Q000502:physiology*; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D011994:Recombinant Proteins / Q000494:pharmacology; D014511:Uremia / Q000235:genetics / Q000503:physiopathology
D002352:Carrier Proteins; D016207:Cytokines; D005938:Glucocorticoids; D007328:Insulin; C515448:LEPR protein, human; D020738:Leptin; D011506:Proteins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D011994:Recombinant Proteins; C515447:leptin receptor, mouse